EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential

Yosef Tsegaye Dabi iD, Abayomi O Ajagbe, Sisay T Degechisa iD

Immunity, Inflammation and Disease · 2023-04 · 11 (4)

DOI: 10.1002/iid3.839 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 19.04.2023. Verfasst von Yosef Tsegaye Dabi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, Institute of Health Sciences, Wollega University, Nekemte, Ethiopia. Hauptthemen laut MEDLINE: Neurodegenerative Diseases. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll‐like receptors (TLRs) are a family of pattern‐recognition receptors triggered by pathogen‐derived and tissue‐damage‐related ligands. TLRs were previously believed to only be expressed in immune cells. However, it is now confirmed that they are ubiquitously expressed in cells within the body including neurons, astrocytes, and microglia of the central nervous system (CNS). Activation of TLRs is capable of inducing immunologic and inflammatory responses to injury or infection of CNS. This response is self‐limiting that usually resolves once the infection has been eradicated or the tissue damage has been repaired. However, the persistence of inflammation‐inducing insults or a failure in normal resolution mechanisms may result in overwhelming inflammation which may induce neurodegeneration. This implies that TLRs may play a role in mediating the link between inflammation and neurodegenerative diseases namely Alzheimer's disease, Parkinson's disease, Huntington's disease, stroke, and amyotrophic lateral sclerosis. So, new therapeutic approaches that specifically target TLRs may be developed by better understanding TLR expression mechanisms in the CNS and their connections to particular neurodegenerative disorders. Therefore, this review paper discussed the role of TLRs in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesHumansToll-Like ReceptorsInflammationMicrogliaNeurons

Stichwörter der Autor:innen

inflammationneurodegenerative diseasestoll-like receptors

Substanzen

Toll-Like Receptors

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, Institute of Health Sciences, Wollega University, Nekemte, Ethiopia.
  • Department of Anatomy, College of Health Sciences, Faculty of Basic Medical Sciences, Nile University of Nigeria, Abuja, Nigeria.
  • Department of Medical Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.

ORCID-Profile: Yosef Tsegaye Dabi, Sisay T Degechisa

Zitieren

APA

Dabi, Y. T., Ajagbe, A. O., & Degechisa, S. T. (2023). Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. Immunity, Inflammation and Disease, 11(4). https://doi.org/10.1002/iid3.839

Vancouver

Dabi YT, Ajagbe AO, Degechisa ST. Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. Immunity, Inflammation and Disease. 2023;11(4). doi:10.1002/iid3.839

BibTeX
@article{Dabi2023,
  author = {Dabi, Yosef Tsegaye and Ajagbe, Abayomi O and Degechisa, Sisay T},
  title = {Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  volume = {11},
  number = {4},
  doi = {10.1002/iid3.839}
}
Kostenlos starten →